Research Progress of HE4 and Vimentin in Endometrial Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Research Progress of HE4 and Vimentin in Endometrial Carcinoma

Published:2023 Issue:04 Volume:13 Page:6489-6495
ISSN:2161-8712
Container-title:Advances in Clinical Medicine
language:
Short-container-title:ACM

Author:

周敏

Publisher

Hans Publishers

Subject

General Engineering

Reference49 articles.

1. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers.

2. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status

3. 王锦, 俞虹, 何建新, 等. 血清和子宫内膜组织CA125和HE4在子宫内膜癌术前评估及不同病理特征中的变化意义[J]. 中国妇幼保健, 2021, 36(11): 2506-2508.

4. HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines

5. Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3